Idhifa has been approved for the treatment of relapsed or refractory acute myeloid leukemia
Acute myeloid leukemia (AML) is an aggressive blood and bone marrow cancer where not all leukemic cells are destroyed...
Oncology
New drug Nerlynx approved by the FDA as new treatment to reduce risk of breast cancer recurrence
With increasing incidences of cancer and its recurrence, the scientific community is always trying to invent new remedies and...
Ribociclib approved as the first-line agent for metastatic breast cancer
Breast cancer is the second leading cause of cancer-related mortality in women, after lung cancer.1 The American Cancer Society...